Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Secures First International Sales Contract worth US$1.9 Million (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

CANEXUS CORP 6.5 PCT DEBS T.CUS.DB.D

Chemicals Specialty Chemicals


TSX:CUS.DB.D - Post by User

CANEXUS CORP 6.5 PCT DEBS > $7.55 a share
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(0)
•••
Comment by Jackroyon Sep 28, 2015 6:09pm
224 Views
Post# 24142902

RE:RE:RE:$7.55 a share

RE:RE:RE:$7.55 a shareCould we not reach back a year on everyone's post and they would be equally as inaccurate.  Kherson beleived this when management was not providing accurate accounts of their construction issue in Bruderhiem.  I beleived it too then.  He has been pretty accurate about the share decline since managment gave him accurate information as to the extent of the problems.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities